261 related articles for article (PubMed ID: 26402733)
1. Targeting Lysine Deacetylases (KDACs) in Parasites.
Wang Q; Rosa BA; Nare B; Powell K; Valente S; Rotili D; Mai A; Marshall GR; Mitreva M
PLoS Negl Trop Dis; 2015; 9(9):e0004026. PubMed ID: 26402733
[TBL] [Abstract][Full Text] [Related]
2. Homology modeling of parasite histone deacetylases to guide the structure-based design of selective inhibitors.
Melesina J; Robaa D; Pierce RJ; Romier C; Sippl W
J Mol Graph Model; 2015 Nov; 62():342-361. PubMed ID: 26595183
[TBL] [Abstract][Full Text] [Related]
3. Evolutionary relationships among protein lysine deacetylases of parasites causing neglected diseases.
Scholte LLS; Mourão MM; Pais FS; Melesina J; Robaa D; Volpini AC; Sippl W; Pierce RJ; Oliveira G; Nahum LA
Infect Genet Evol; 2017 Sep; 53():175-188. PubMed ID: 28506839
[TBL] [Abstract][Full Text] [Related]
4. Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites.
Engel JA; Jones AJ; Avery VM; Sumanadasa SD; Ng SS; Fairlie DP; Skinner-Adams T; Andrews KT
Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):117-26. PubMed ID: 26199860
[TBL] [Abstract][Full Text] [Related]
5. Repurposing Anticancer Drugs To Tackle Malaria.
Le Govic Y; Houzé S; Papon N
ChemMedChem; 2021 Jul; 16(14):2192-2194. PubMed ID: 33931947
[TBL] [Abstract][Full Text] [Related]
6. Hydroxamic acid based histone deacetylase inhibitors with confirmed activity against the malaria parasite.
Giannini G; Battistuzzi G; Vignola D
Bioorg Med Chem Lett; 2015 Feb; 25(3):459-61. PubMed ID: 25563890
[TBL] [Abstract][Full Text] [Related]
7. Mining a cathepsin inhibitor library for new antiparasitic drug leads.
Ang KK; Ratnam J; Gut J; Legac J; Hansell E; Mackey ZB; Skrzypczynska KM; Debnath A; Engel JC; Rosenthal PJ; McKerrow JH; Arkin MR; Renslo AR
PLoS Negl Trop Dis; 2011 May; 5(5):e1023. PubMed ID: 21572521
[TBL] [Abstract][Full Text] [Related]
8. A novel approach for the discovery of chemically diverse anti-malarial compounds targeting the Plasmodium falciparum Coenzyme A synthesis pathway.
Fletcher S; Avery VM
Malar J; 2014 Aug; 13():343. PubMed ID: 25174342
[TBL] [Abstract][Full Text] [Related]
9. In silico identification of inhibitors against Plasmodium falciparum histone deacetylase 1 (PfHDAC-1).
Kumar A; Dhar SK; Subbarao N
J Mol Model; 2018 Aug; 24(9):232. PubMed ID: 30109440
[TBL] [Abstract][Full Text] [Related]
10. Design and Synthesis of Novel Anti-Plasmodial Histone Deacetylase Inhibitors Containing an Alkoxyamide Connecting Unit.
Alves Avelar LA; Held J; Engel JA; Sureechatchaiyan P; Hansen FK; Hamacher A; Kassack MU; Mordmüller B; Andrews KT; Kurz T
Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28317157
[TBL] [Abstract][Full Text] [Related]
11. Screening a Natural Product-Based Library against Kinetoplastid Parasites.
Zulfiqar B; Jones AJ; Sykes ML; Shelper TB; Davis RA; Avery VM
Molecules; 2017 Oct; 22(10):. PubMed ID: 29023425
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of the antiplasmodial activity of Hsp90 inhibitors.
Murillo-Solano C; Dong C; Sanchez CG; Pizarro JC
Malar J; 2017 Jul; 16(1):292. PubMed ID: 28724415
[TBL] [Abstract][Full Text] [Related]
13. Activity of alkoxyamide-based histone deacetylase inhibitors against Plasmodium falciparum malaria parasites.
Dawood WA; Fisher GM; Kinnen FJM; Anzenhofer C; Skinner-Adams T; Alves Avelar L; Asfaha Y; Kurz T; Andrews KT
Exp Parasitol; 2024 Mar; 258():108716. PubMed ID: 38340779
[TBL] [Abstract][Full Text] [Related]
14. Lysine deacetylase (KDAC) regulatory pathways: an alternative approach to selective modulation.
Van Dyke MW
ChemMedChem; 2014 Mar; 9(3):511-22. PubMed ID: 24449617
[TBL] [Abstract][Full Text] [Related]
15. Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives.
Hailu GS; Robaa D; Forgione M; Sippl W; Rotili D; Mai A
J Med Chem; 2017 Jun; 60(12):4780-4804. PubMed ID: 28241112
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis for the antiparasitic activity of a mercaptoacetamide derivative that inhibits histone deacetylase 8 (HDAC8) from the human pathogen schistosoma mansoni.
Stolfa DA; Marek M; Lancelot J; Hauser AT; Walter A; Leproult E; Melesina J; Rumpf T; Wurtz JM; Cavarelli J; Sippl W; Pierce RJ; Romier C; Jung M
J Mol Biol; 2014 Oct; 426(20):3442-53. PubMed ID: 24657767
[TBL] [Abstract][Full Text] [Related]
17. Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth.
Chua MJ; Arnold MS; Xu W; Lancelot J; Lamotte S; Späth GF; Prina E; Pierce RJ; Fairlie DP; Skinner-Adams TS; Andrews KT
Int J Parasitol Drugs Drug Resist; 2017 Apr; 7(1):42-50. PubMed ID: 28107750
[TBL] [Abstract][Full Text] [Related]
18. Design and Synthesis of Simplified Largazole Analogues as Isoform-Selective Human Lysine Deacetylase Inhibitors.
Reddy DN; Ballante F; Chuang T; Pirolli A; Marrocco B; Marshall GR
J Med Chem; 2016 Feb; 59(4):1613-33. PubMed ID: 26681404
[TBL] [Abstract][Full Text] [Related]
19. Biological characterization of chemically diverse compounds targeting the Plasmodium falciparum coenzyme A synthesis pathway.
Fletcher S; Lucantoni L; Sykes ML; Jones AJ; Holleran JP; Saliba KJ; Avery VM
Parasit Vectors; 2016 Nov; 9(1):589. PubMed ID: 27855724
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of benzodiazepine analogs as isoform-selective human lysine deacetylase inhibitors.
Reddy DR; Ballante F; Zhou NJ; Marshall GR
Eur J Med Chem; 2017 Feb; 127():531-553. PubMed ID: 28109947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]